Leukotriene D4 (2 c 10(-9) mole), injected into the left circumflex coronary artery of anesthetized sheep, produced profound coronary vasoconstriction and impaired regional ventricular wall motion. This cardiac effect was neither inhibited by prior treatment of the sheep with a cyclooxygenase inhibitor nor associated with thromboxane B2 release into the coronary sinus. Intravenous FPL 55712 completely abolished the coronary vasoconstriction of leukotriene D4, but a significant reduction of regional wall shortening persisted.

ABSTRACT:In recent years more attention has been paid to the issue of pain in animals, particularly in association with increasing awareness of animal welfare. It is therefore necessary for veterinarians to be able recognise unambiguously whether an animal suffers from pain. Adult humans suffering from pain can more or less characterise their painful experiences, including the site and intensity of the pain. However, pain in animals is in some aspects more complex and it can be rather difficult to evaluate the seriousness and impact of painful events. Therefore, in animals we have to recognise the signs of pain according to indirect markers which involve behavioural, physiological and finally clinical responses. Moreover, in particular the behavioural changes associated with pain can be along with the general signs also species-specific, and hardly recognisable (and for an inexperienced observer seemingly unimportant) which makes pain assessment even more complicated. Therefore, the current review formulates definitions of pain, its classification and is focused on methods that may facilitate pain recognition in animals, which is crucial for an effective pain assessment and consequent effective pain management. The review combines recent knowledge with well proven facts concerning pain and furthermore also highlights the author's own research on pain assessment.

Cannabinoids/medical marijuana and their possible therapeutic use have received increased attention in human medicine during the last years. This increased attention is also an issue for veterinarians because particularly companion animal owners now show an increased interest in the use of these compounds in veterinary medicine. This review sets out to comprehensively summarise well known facts concerning properties of cannabinoids, their mechanisms of action, role of cannabinoid receptors and their classification. It outlines the main pharmacological effects of cannabinoids in laboratory rodents and it also discusses examples of possible beneficial use in other animal species (ferrets, cats, dogs, monkeys) that have been reported in the scientific literature. Finally, the article deals with the prospective use of cannabinoids in veterinary medicine. We have not intended to review the topic of cannabinoids in an exhaustive manner; rather, our aim was to provide both the scientific community and clinical veterinarians with a brief, concise and understandable overview of the use of cannabinoids in veterinary medicine.

No abstract